期刊文献+

甲状腺功能减退导致高甘油三酯血症的分子机制的新认识 被引量:5

A new sight into mechanism of hypertriglyceridemia induced by hypothyroidism
原文传递
导出
摘要 高甘油三酯血症是甲状腺功能减退症(甲减)的临床表现之一.促甲状腺素(thyroid stimulating hormone,TSH)除调节甲状腺激素轴外,还具有上调炎性细胞因子表达的作用.而炎性因子可促进小肠粘膜上皮细胞载脂蛋白B48(apolipoprotein B48)的合成,这提示TSH可能通过促发炎症而上调ApoB48表达;而理论上,低TH可抑制ApoB48合成.同时,由于Apol48是血清高甘油三酯血症的重要原因,上述矛盾难以解释甲状腺功能减退导致高甘油三酯的临床现象.因此,甲状腺功能减退可能是通过高TSH、低甲状腺激素水平影响ApoB48的表达,进而导致甘油三酯增高. Hypertriglyceridemia is one of the clinical manifestations of hypothyroidism.Besides regulating thyroid hormone axis,thyroid stimulating hormone (TSH) also has the effect on up-regulated expression of inflammatory cytokines.Synthesis of inflammatory factors can promote the expression of apolipoprotein B48 (ApoB48) in intestinal mucosal epithelial cells,suggesting that TSH may up-regulate the expression of ApoB48 by inducing inflammation; while theoratically,low-level of thyroid hormones can inhibit the synthesis of ApoB48.At the same time,since ApoB48 is the important cause of hypertriglyceridemia,there is a contradiction that it is difficult to explain the clinical phenomenon of hypertriglyceridemia induced by hypothyroidism.Therefore,hypothyroidism may affect the expression of ApoB48 by high level of TSH and low level of thyroid hormones,leading to hypertriglyceridemia.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2014年第10期856-858,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 甲状腺功能减退症 高甘油三酯血症 载脂蛋白B48 Hypothyroidism Hypertriglyceridemia Apolipoprotein B48
  • 相关文献

参考文献30

  • 1Welty FK,Lichtenstein AH,Barrett PH,et al.Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes[J].Arterioscler Thromb Vasc Biol,1999,19:2966-2974.
  • 2Pearce EN.Update in lipid alterations in subclinical hypothyroidism[J].J Clin Endocrinol Metab,2012,97:326-333.
  • 3Wang J,Whetsell M,Klein JR.Local hormone networks and intestinal T cell homeostasis[J].Science,1997,275:1937-1939.
  • 4Mugii S,Hanada H,Okubo M,et al.Thyroid function influences serum apolipoprotein B-48 levels in patients with thyroid disease[J].J Atheroscler Thromb,2012,19:890-896.
  • 5van der Poll T,van Zee KJ,Endert E,et al.Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man[J].J Clin Endocrinol Metab,1995,80:1341-1346.
  • 6Feingold KR,Staprans I,Memon RA,et al.Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia:low doses stimulate hepatic triglyceride production while high doses inhibit clearance[J].J Lipid Res,1992,33:1765-1776.
  • 7Qin B,Qiu w,Avramoglu RK,et al.Tumor necrosis factor-α induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins[J].Diabetes,2007,56:450-461.
  • 8Qin B,Dawson H,Anderson RA.Elevation of tumor necrosis factor-α induces the overproduction of postprandial intestinal apolipoprotein B48-containing very low-density lipoprotein particles:evidence for related gene expression of inflammatory,insulin and lipoprotein signaling in enterocytes[J].Exp Biol Med(Maywood),2010,235:199-205.
  • 9Federico LM,Naples M,Taylor D,et al.Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia:evidence for activation of protein tyrosine phosphatase-1B,extracellular signal-related kinase,and sterol regulatory element-binding protein-1 c in the fructose-fed hamster intestine[J].Diabetes,2006,55:1316-1326.
  • 10Lewis GF,Uffelman K,Naples M,et al.Intestinal lipoprotein overproduction,a newly recognized component of insulin resistance,is ameliorated by the insulin sensitizer rosiglitazone:studies in the fructose-fed Syrian golden hamster[J].Endocrinology,2005,146:247-255.

同被引文献45

  • 1VONDRA K,VRBIKOVA J,DVORAKOVA K. Thyroid gland diseases in adult patients with diabetes meUitus[J]. Minerva Endocrinol,2005,30:217-236.
  • 2CHUBB SAP, DAVIS WA, DAVIS TME. Interaction among thyroid fuction, insulin sensitivity and serum lipid concen- tractions:the Framantle Diabetes Study[J]. J Clin Endocrinol Metab, 2005, 90: 5317-5320.
  • 3MUGII S, HANADA H, OKUBO M, et al. Thyroid func- tion influences serum apolipoprotein B48 levels in patients with thyroid disease [J]. J Atheroscler Thromb,2012,19: 890-896.
  • 4Maskey R, Shakya DR, Baranwal JK, et al. Hypothyroidism indiabetes mellitus patients in Eastern Nepal [ J]. Indian J EtdocrinolMetab,2015, 19 (3) : 411 -415.
  • 5Kadiyala R, Peter R, Okosieme OE. Thyroid dysfunction in patientswith diabetes : clinical implication and screening strategies [ J ]. IntClin Pract, 2010,64 (8) ; 1130-1139.
  • 6Choe EY, Wang HJ, Kwon 0, et al. Variants of the adiponectingene and diabetic microvascular complications in patients with type 2diabetes [J]. Metabolism, 2013, 62 (5) : 677 -685.
  • 7Ansar H, Mirzaei K, Malek A, et al. Possible resting metabolic ratemodification by the circulating RBP4 in obese subjects [ J]. DiabetesMetab Syndr, 2015,9 (1): 19—23.
  • 8Xu Y, Wang L,He J, et al. Prevalence and control of diabetes inChinese adults [J]. JAMA, 2013, 310: 948 -959.
  • 9Mao D,Peng H,Li Q, et al. Aqueous humor and plasmaadiponectin levels in proliferative diabetic retinopathy patients [ J].Curr Eve Res, 2012, 37 (9) : 803 -808.
  • 10Li ZZ, Lu XZ, Liu JB,et al. Serum retinol - binding protein 4levers in patients with diabetic retinopathy [ J ]. J Int Med Res,2010, 38 (1) : 95 -99.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部